AI assistant
Sending…
EXACT Therapeutics AS — Director's Dealing 2023
Dec 1, 2023
3600_dirs_2023-12-01_5966c8eb-1498-44f3-a34e-76e04010c6c8.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Notification of transactions by Primary Insiders and Close Associates
| 1 | Details of the Primary Insider/Close Associate | |||
|---|---|---|---|---|
| a) | Name | Per Walday | ||
| 2 | ||||
| a) | Position/status | The notification concerns a Primary insider: Per Walday (CEO) |
||
| b) | Initial notification/ Amendment |
Initial notification | ||
| 3 | Details of Nordhealth AS, emission allowance market participant, auction platform, | |||
| auctioneer or auction monitor | ||||
| a) | Name | EXACT Therapeutics AS | ||
| b) | LEI | 2138006ZE5JAL39AGD55 | ||
| 4 | ||||
| a) | Description of the | Nature of the instrument: Share | ||
| financial instrument, type | ||||
| of instrument | Instrument of identification code (ISIN): NO 0010852213 | |||
| Identification code | ||||
| b) | Nature of the transaction | Disposal | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| 12 per share |
8,333 | |||
| d) | Aggregated information | Price: 99,996 Volume: 8,333 |
||
| - Aggregated volume | ||||
| - Price | ||||
| e) | Date of the transaction | 2023-11-30 | ||
| f) | Place of the transaction | Oslo Børs |
More from EXACT Therapeutics AS
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Delisting Announcement
2026
May 29
Annual Report
2026
Apr 9
Report Publication Announcement
2026
Apr 9
Share Issue/Capital Change
2026
Mar 26
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 13
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 13
Regulatory Filings
2026
Mar 3
Proxy Solicitation & Information Statement
2026
Feb 27